
HYTN, a company specializing in pharmaceutical-grade cannabis manufacturing, has entered into a collaboration agreement with SNDL to jointly develop Good Manufacturing Practices (GMP) compliant vape cartridges.
Leveraging HYTN’s GMP-certified facility and expertise in quality system development, SNDL will provide specialized equipment, cannabis consumables, and the required capital to meet stringent regulatory requirements for GMP product development. HYTN will look to amend its licenses and/or certificates, establish a stability program, and implement GMP-compliant processes tailored for vape cartridge production.
Under the terms of the agreement, neither HYTN nor SNDL are obligated to exclusivity. While key milestones include the processing of three commercial batches, there is no obligation regarding sales volume or pricing terms. Upon completion of the development phase, both parties may explore a commercial manufacturing agreement for vape cartridges.